Prolo, L. M., Li, A., Morgens, D., Reimer, R., Bassik, M., & Grant, G. A. (2017). 137 Novel Genome-wide CRISPR Screen for Glioblastoma Invasion. In Neurosurgery (Vol. 64, pp. 232–232). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1093/neuros/nyx417.137

Prolo, Laura Marie, Amy Li, David Morgens, Richard Reimer, Michael Bassik, and Gerald A. Grant. “137 Novel Genome-wide CRISPR Screen for Glioblastoma Invasion.” In Neurosurgery, 64:232–232. Ovid Technologies (Wolters Kluwer Health), 2017. https://doi.org/10.1093/neuros/nyx417.137.

Prolo LM, Li A, Morgens D, Reimer R, Bassik M, Grant GA. 137 Novel Genome-wide CRISPR Screen for Glioblastoma Invasion. In: Neurosurgery. Ovid Technologies (Wolters Kluwer Health); 2017. p. 232–232.

Prolo, Laura Marie, et al. “137 Novel Genome-wide CRISPR Screen for Glioblastoma Invasion.” Neurosurgery, vol. 64, no. CN_suppl_1, Ovid Technologies (Wolters Kluwer Health), 2017, pp. 232–232. Crossref, doi:10.1093/neuros/nyx417.137.

Prolo LM, Li A, Morgens D, Reimer R, Bassik M, Grant GA. 137 Novel Genome-wide CRISPR Screen for Glioblastoma Invasion. Neurosurgery. Ovid Technologies (Wolters Kluwer Health); 2017. p. 232–232.